Member Policies - Medical Policies - Alabama
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Policies
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Draft Medical Policies
Draft policies are listed below. If there are no policies listed, it means there are currently no policies in draft status.
Comment on Draft Medical Policies
Participating providers are invited to submit for consideration scientific, evidence-based information, professional consensus opinions, and other information supported by medical literature relevant to our draft policies.
Comments are accepted for 45 days from the posting date listed on the draft policy.
Make sure your voice is heard by providing feedback directly to us:
- Complete our medical policy feedback form online, or
- Send comments and supporting documentation by mail or fax
Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001
Fax: 205-220-0878
Draft Policies
| Policy # | Policy Title | Print View |
|---|---|---|
| MP-225 | Balloon Ostial Dilation for Treatment of Sinusitis | |
| MP-755 | Digital Health Technologies: Therapeutic Applications |
Node: bclrgrpappp1001.corp.bcbsal.org:8080